One-Step Robot-Assisted Complete Urinary Tract Extirpation in Man with End-Stage Renal Disease on Dialysis: The First Case Report.

Urothelial carcinoma (UC) could be observed in urinary bladder (UBUC) and upper urinary tracts (UTUC). In the National Comprehensive Cancer Network guidelines for bladder cancer, extirpative surgery is indicated in certain cases. However, some extreme cases might also need the extirpation of the majority of the urinary tract, which is called complete urinary tract extirpation (CUTE). We present a patient diagnosed with high-grade UBUC and UTUC. He underwent dialysis for end-stage renal disease (ESRD) at the same time. Considering his non-functional kidneys and removing his high-risk urothelium at the same time, we performed robot-assisted CUTE to extirpate both his upper urinary tracts, urinary bladder, and prostate. In our experience, the console time was not significantly elongated, and the perioperative course was uneventful. To our knowledge, this is the first case report adopting a robotic system in such an extreme case. We conclude that robot-assisted CUTE is worth further study regarding its oncological survival outcomes and perioperative safety in patients with ESRD on dialysis.

High success rate with new modified endoscopic treatment for high-grade VUR: A pilot study with preliminary report.

PURPOSE: Despite the benefits of the minimally invasive endoscopic treatment for vesicoureteral reflux (VUR) it has a major drawback which is low success rate in high grade VUR. For overcoming this problem, we introduce a new modified technique of endoscopic treatment called periureteral injection technique (PIT). MATERIALS AND METHODS: In a prospective study a total of 37 ureters in 19 boys and 14 girls were treated, including 3 bilateral cases. Of 37 units, 30 (81.1%) had grade IV and 7 (18.9%) had grade V primary VUR (18 right, 13 left and 3 bilateral units). Subureteral injection of Vantris(®) was done at the 5-o'clock and 7-o'clock positions in which the direction of injecting needles were almost parallel. Pre- and post-operative evaluation included urinalysis, urinary tract ultrasonography, voiding cystourethrography (VCUG), dimercaptosuccinic acid scan and urodynamic studies. RESULTS: The median age was 38 months (range 8-125). At 6 months follow up period confirmed with VCUG, the VUR has been disappeared in 34 (91.8%) units and 3 units [2 (5.4%) grade II and 1 (2.7%) had grade III)] had downgraded VUR. Complications included early fever due to urinary tract infection in 1 children, transient dysuria in 2 patients and low back pain in one patient (Summary Table). CONCLUSION: The success rate of PIT for treatment of high grade VUR is high. However, further studies with more patients and longer follow up periods are needed to draw final conclusion.

Modified pubovaginal sling technique in the surgical management of female stress urinary incontinence / Técnica modificada do sling pubovaginal no tratamento cirúrgico da incontinência urinária de esforço feminina

Objective: To assess the application of aponeurotic sling by a modified technique with direct visualization of needles in patients with stress urinary incontinence. Methods: we applied the Kings Health Questionnaire (KHQ) for quality of life, gynecological examination, urinalysis I and urine culture approximately seven days prior to the urodynamic study (UDS) and the one-hour PAD test in patients undergoing making aponeurotic sling with its passing through the retropubic route with direct visualization of the needle, PAD test and King's Helth Questionnaire before and after surgery. Results: The mean age was 50.6 years, BMI of 28 and Leak Pressure (LP) 58,5cm H2O; 89% were Caucasian. Forty-six of them were monitored for three and six months, 43 for 12 months. The objective cure rate at 12 months postoperatively was approximately 93.5%. In evaluating quality of life, we observed a significant improvement in 12 months postoperatively compared with the preoperative period. There was no no urethral/bladder injury. As adverse results, we had one persistent urinary retention (2.3%), who was submitted to urethrolysis, currently without incontinence. Conclusion: The proposed procedure is safe as for the risk of bladder or urethral injuries, promoting significant improvement in quality of life and objective cure.

Objetivo: avaliar a aplicação de faixa aponeurótica por técnica modificada com visibilização direta das agulhas em pacientes com incontinência urinária de esforço. Métodos: foi aplicado o questionário Kings Health Questionaire (KHQ) de qualidade de vida, exame ginecológico, exame de urina I e urocultura aproximadamente sete dias antes da realização do estudo urodinâmico (EUD) e PAD test de uma hora submetidas à confecção de faixa aponeurótica com passagem de faixa pela via retropúbica, com agulha sob visibilização direta, PAD test e King´s Helth Questionaire, no pré e pós operatórios. Resultados: a média de idade foi 50,6 anos, 89% da cor branca, IMC de 28 e PPE de 58,5cm de H2O. Quarenta e seis delas tiveram acompanhamento de três e seis meses, 43 de 12 meses. A taxa de cura objetiva, em 12 meses de pós-operatório foi aproximadamente 93,5%. Ao avaliarmos a qualidade de vida das pacientes, observamos a melhora significante em 12 meses de pós-operatório, quando comparada ao pré-operatório. Não foi observada nenhuma lesão uretral/vesical. Como resultados adversos tivemos uma retenção urinária persistente (2,3%), sendo submetida à uretrolíse, estando atualmente sem perda. Conclusão: a operação proposta é segura quanto ao risco de lesões vesicais ou uretrais, promovendo melhora acentuada na qualidade de vida e cura objetiva.

Cytoprotective role of heme oxygenase-1 upregulation in progressive renal disease / Papel citoprotetor da indução da heme oxigenase-1 na lesão renal progressiva

Objective: This study evaluated the ability of heme oxygenase-1 to prevent or reverse renal fibrosis. Methods: Sprague-dawley male rats were submitted to unilateral ureteral obstruction and divided into groups: non-treated and hemin. Biochemical and histological analyses were performed. We also conducted RT-PCR to verify the expression of heme oxygenase-1, MCP-1, IL1-beta, IL-6, TNF-alfa, COL-I, COL-III, PAI-1 and fibronectin mRNA. Results: heme oxygenase-1 expression significantly increased in treated animals. The non treated group showed significantly higher levels of proteinuria than the Hemin group. The protein/urinary creatinine ratio in obstructed pelvis was also higher in non treated group, which also showed greater albuminuria and higher percentage of fibrosis when compared to the Hemin group. The expression of pro-inflammatory and pro-fibrotic molecules was significantly higher in the non treated group. Conclusions: The treatment induced the expression of heme oxygenase-1, preventing the installation of fibrosis and even limiting its progression.

Objetivo: Este estudo avaliou a capacidade da heme oxigenase-1 em prevenir ou reverter o quadro de fibrose renal. Métodos: Ratos Sprague-dawley machos foram submetidos a UUO e divididos nos grupos: não-tratados e Hemin. Avaliou-se a função renal, fez-se análise histológica e realizou-se RT-PCR para verificar expressão de heme oxigenase-1, MCP-1, IL1-beta, IL-6, TNF-alfa, COL-I, COL-III, PAI-1 e Fibronectina. Resultados: Houve expressão significativamente maior de heme oxigenase-1 nos animais tratados. O grupo não tratado apresentou níveis significativamente maiores de proteinúria em relação ao grupo Hemin. O índice proteína/creatinina urinária da pelve obstruída também foi maior no grupo não tratado, que apresentou ainda maior albuminúria e maior porcentagem de fibrose em relação ao grupo Hemin. A expressão de moléculas pró-inflamatórias e pró-fibróticas foi significativamente maior no grupo não tratado. Conclusões: O tratamento induziu a expressão de heme oxigenase-1, evitando a instalação da fibrose e mesmo limitando sua progressão.